Urgent need for the continued development of targeted treatment for NSCLC after study 'shows potential' 05-Jun-2023 By Liza Laws There is an urgent need for more targeted treatment options for patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), although first-line treatment has shown potential in a clinical study.